Your prescriber’s plan, in a dated table.
Enter the steps your provider set — each weekly dose and how many weeks you stay on it. The planner dates them out and, for compounded vials, shows the units to draw. For tracking & education only — it never recommends a dose or a schedule.
Set a plan start date and add at least one step (weekly dose + whole weeks) to see your dated schedule here.
Lumara is a tracking tool and does not provide medical advice, diagnosis, or treatment. This planner only dates the steps you enter — it never recommends a schedule, a dose, or a change. Always follow your provider’s plan.
How to plan a GLP-1 titration schedule
Titration means stepping a GLP-1 dose up gradually, staying at each level for a set number of weeks. This planner turns the steps your prescriber gave you into dated calendar weeks — it does not decide the steps.
- Set your start date so every step lands on real calendar weeks.
- Add each step your provider set — the weekly dose and how many weeks you stay on it.
- Add your compounded vial (optional) to see the units to draw at each step.
- Read the dated schedule and track which week you are on — edit any step as your plan changes.
Worked example: a common step-up ladder
Many semaglutide plans step up every four weeks. Your prescriber sets the actual doses — this is only an illustration of how steps become dates:
- Weeks 1–4 — step 1 (e.g. 0.25 mg weekly).
- Weeks 5–8 — step 2 (e.g. 0.5 mg weekly).
- Weeks 9+ — step 3 (e.g. 1.0 mg weekly), or wherever your prescriber holds you.
- Compounded vials — each step also shows the units to draw at that dose.
Enter your own steps above — the planner dates them from your start date and stays fully editable. It never suggests doses or how long to stay on them.
Sources
- WEGOVY (semaglutide) injection, for subcutaneous use; WEGOVY (semaglutide) tablets, for oral use. Full prescribing information. Novo Nordisk; revised 6/2026. DailyMed, U.S. National Library of Medicine.
- ZEPBOUND (tirzepatide) injection, for subcutaneous use. Full prescribing information. Eli Lilly and Company; revised 8/2026. DailyMed, U.S. National Library of Medicine.
- U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.
Frequently asked questions
Titration is stepping the dose up gradually over weeks rather than starting at a target dose, which is common with GLP-1 medications. The specific doses and timing are set by your prescriber; this planner just lays those steps onto a dated schedule.
Yes. Every step — the dose and how many weeks you stay on it — is editable, and the schedule re-dates itself from your start date. The tool never fixes or recommends a plan; it reflects whatever your provider set.
Yes. If you add a compounded vial (strength and water), each step in the schedule also shows the insulin-syringe units to draw at that dose, using the same math as the GLP-1 Dose Calculator.
No. It is an educational tracking tool. It organises the plan you enter into dates and units and shows its work; it never recommends a dose or a schedule. Always follow your licensed provider’s instructions.